These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29782862)

  • 1. Evaluation of cardiac arrhythmic risks using a rabbit model of left ventricular systolic dysfunction.
    Hemmeryckx B; Feng Y; Frederix L; Lox M; Trenson S; Vreeken R; Lu HR; Gallacher D; Ni Y; Lijnen HR
    Eur J Pharmacol; 2018 Aug; 832():145-155. PubMed ID: 29782862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring reperfused myocardial infarction with delayed left ventricular systolic dysfunction in rabbits by longitudinal imaging.
    Feng Y; Hemmeryckx B; Frederix L; Lox M; Wu J; Heggermont W; Lu HR; Gallacher D; Oyen R; Lijnen HR; Ni Y
    Quant Imaging Med Surg; 2018 Sep; 8(8):754-769. PubMed ID: 30306056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Index of Cardio-Electrophysiological Balance (iCEB) as a New Biomarker for the Identification of Patients at Increased Arrhythmic Risk.
    Robyns T; Lu HR; Gallacher DJ; Garweg C; Ector J; Willems R; Janssens S; Nuyens D
    Ann Noninvasive Electrocardiol; 2016 May; 21(3):294-304. PubMed ID: 26305685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of combined amiodarone and antiarrhythmic peptide use on the cardiac gap junctions and incidence of induced ventricular arrhythmias in healed myocardial infarction rabbit models].
    Li LD; Zhang CT; Ruan L; Ni MK; Fang Y; Wang GQ; Wang XF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1102-7. PubMed ID: 21215147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart.
    Osadchii OE
    Scand Cardiovasc J; 2016; 50(1):28-35. PubMed ID: 26402340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological and haemodynamic effects of vernakalant and flecainide in dyssynchronous canine hearts.
    van Middendorp LB; Strik M; Houthuizen P; Kuiper M; Maessen JG; Auricchio A; Prinzen FW
    Europace; 2014 Aug; 16(8):1249-56. PubMed ID: 24481779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flecainide acetate on reperfusion- and barium-induced ventricular tachyarrhythmias in the isolated perfused rat heart.
    Ferrara N; Abete P; Leosco D; Caccese P; Orlando M; Landino P; Sederino S; Tedeschi C; Rengo F
    Arch Int Pharmacodyn Ther; 1990; 308():104-14. PubMed ID: 2129150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction.
    Hashimoto H; Katoh H; Nakashima M
    J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; ten Cate FJ; Jovanovic A; Hagemeijer F; Withagen A; Polak BC; Roelandt J; Hugenholtz PG
    Eur Heart J; 1984 Oct; 5(10):814-23. PubMed ID: 6499854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel, minimally invasive, segmental myocardial infarction with a clear healed infarct borderzone in rabbits.
    Ziv O; Schofield L; Lau E; Chaves L; Patel D; Jeng P; Peng X; Choi BR; Koren G
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2321-30. PubMed ID: 22447944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic ventricular arrhythmias during heart failure: a canine model to replicate clinical events.
    Issa ZF; Rosenberger J; Groh WJ; Miller JM; Zipes DP
    Heart Rhythm; 2005 Sep; 2(9):979-83. PubMed ID: 16171754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and incidence of inducible monomorphic ventricular tachycardia in a postinfarction rabbit model.
    McLachlan CS; McGuire MA
    J Electrocardiol; 2007 Jan; 40(1):89-93. PubMed ID: 17027019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of flecainide on atrial and ventricular stimulation thresholds to repetitive extrasystoles and fibrillation and on "2nd Phase" ventricular arrhythmias in dogs.
    Heuer H; Gülker H; Thale J; Bender F
    Arzneimittelforschung; 1983; 33(12):1651-4. PubMed ID: 6199033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP; van der Linde HJ; Van Deuren B; Somers Y; Lubomirski M; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2015; 72():72-84. PubMed ID: 25450838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased intra-QRS fragmentation in magnetocardiography as a predictor of arrhythmic events and mortality in patients with cardiac dysfunction after myocardial infarction.
    Korhonen P; Husa T; Tierala I; Väänänen H; Mäkijärvi M; Katila T; Toivonen L
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):396-401. PubMed ID: 16643362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of closed chest regional myocardial infarction in the rabbit: a clinically relevant in vivo assay system of post-infarction remodelling.
    Edwards R; Yousef Z; Rakhit R; Wright M; Rosenthal E; Redwood S; Marber M
    Basic Res Cardiol; 2002 Sep; 97(5):374-83. PubMed ID: 12200637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paced QT interval as a risk factor for new-onset left ventricular systolic dysfunction and cardiac death after permanent pacemaker implantation.
    Cho EJ; Park SJ; Park KM; On YK; Kim JS
    Int J Cardiol; 2016 Jan; 203():158-63. PubMed ID: 26523358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.